Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
Clinical trial NCT04000009 · TERMINATED
Trial details
- NCT number
- NCT04000009
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2021-02-22
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.